Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007
Published online before print May 24, 2007, doi: 10.1161/CIRCRESAHA.107.149435
A more recent version of this article appeared on July 6, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/1/106    most recent
CIRCRESAHA.107.149435v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, A. P.
Right arrow Articles by Moreno, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, A. P.
Right arrow Articles by Moreno, P. R.
Related Collections
Right arrow Pathophysiology

Submitted on January 28, 2007
Revised on May 15, 2007
Accepted on May 16, 2007

Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype. Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability

Andrew P. Levy *; K. Raman Purushothaman ; Nina S. Levy ; Meerarani Purushothaman ; Merav Strauss ; Rabea Asleh ; Stuart Marsh ; Osher Cohen ; Soren K. Moestrup ; Holger J. Moller ; Elias A. Zias ; Daniel Benhayon ; Valentin Fuster ; and Pedro R. Moreno

From the Faculty of Medicine (A.P.L., N.S.L., M.S., R.A., S.M., O.C.), Technion-Israel Institute of Technology, Haifa, Israel; the Department of Medical Biochemistry (S.K.M.), University of Aarhus, and the Department of Clinical Biochemistry (H.J.M.), AS Aarhus University Hospital, Aarhus, Denmark; and the Department of Cardiology (K.R.P., M.P., E.A.Z., D.B., V.F., P.M.), Mt Sinai Medical Center, New York.

* To whom correspondence should be addressed. E-mail: alevy{at}tx.technion.ac.il.

In individuals with diabetes mellitus (DM), the haptoglobin (Hp) genotype is a major determinant of susceptibility to myocardial infarction. We have proposed that this is because of DM and Hp genotype-dependent differences in the response to intraplaque hemorrhage. The macrophage hemoglobin scavenging receptor CD163 plays an essential role in the clearance of hemoglobin released from lysed red blood cells after intraplaque hemorrhage. We sought to test the hypothesis that expression of CD163 is DM and Hp genotype-dependent. CD163 was quantified in plaques by immunohistochemistry, on peripheral blood monocytes (PBMs) by FACS, and as soluble CD163 (sCD163) in plasma by ELISA. In DM plaques, despite an increase in macrophage infiltration, CD163 immunoreactivity was lower, resulting in a dramatic reduction in the percentage of macrophages expressing CD163 (27±2% versus 70±2%, P=0.0001). In individuals with DM as compared with individuals without DM, the percentage of PBMs expressing CD163 was reduced (3.7±0.6% versus 7.1±0.9%, P<0.002) whereas soluble plasma CD163 was increased (2.6±1.1 µg/mL versus 1.6±0.8 µg/mL, P<0.0005). Among DM individuals, the Hp 2-2 genotype was associated with a decrease in the percentage of PBMs expressing CD163 (2.3±0.5% versus 5.6±1.3%, P=0.01) and an increase in plasma soluble CD163 (3.0±0.2 µg/mL versus 2.3±0.2 µg/mL, P=0.04). Taken together, these results demonstrate an impaired hemoglobin clearance capacity in Hp 2-2 DM individuals and may provide the key insight explaining the increased incidence of myocardial infarction in this population.


Key words: diabetes mellitus • hemoglobin • macrophage • intraplaque hemorrhage • haptoglobin polymorphism




This article has been cited by other articles:


Home page
Eur Heart JHome page
F. Crea and F. Andreotti
The unstable plaque: a broken balance
Eur. Heart J., August 1, 2009; 30(15): 1821 - 1823.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. R. Sipido, A. Tedgui, S. D. Kristensen, G. Pasterkamp, H. Schunkert, M. Wehling, P. G. Steg, W. Eisert, F. Rademakers, B. Casadei, et al.
Identifying needs and opportunities for advancing translational research in cardiovascular disease
Cardiovasc Res, August 1, 2009; 83(3): 425 - 435.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. Moreno, J. Sanz, and V. Fuster
Promoting Mechanisms of Vascular Health: Circulating Progenitor Cells, Angiogenesis, and Reverse Cholesterol Transport
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2315 - 2323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. M. Nakhoul, R. Miller-Lotan, H. Awad, R. Asleh, K. Jad, N. Nakhoul, R. Asaf, N. Abu-Saleh, and A. P. Levy
Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F830 - F838.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. J. Boyle, H. A. Harrington, E. Piper, K. Elderfield, J. Stark, R. C. Landis, and D. O. Haskard
Coronary Intraplaque Hemorrhage Evokes a Novel Atheroprotective Macrophage Phenotype
Am. J. Pathol., March 1, 2009; 174(3): 1097 - 1108.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Asleh, S. Blum, S. Kalet-Litman, J. Alshiek, R. Miller-Lotan, R. Asaf, W. Rock, M. Aviram, U. Milman, C. Shapira, et al.
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
Diabetes, October 1, 2008; 57(10): 2794 - 2800.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. Moreno, K. R. Purushothaman, M. Purushothaman, P. Muntner, N. S. Levy, V. Fuster, J. T. Fallon, P. A. Lento, A. Winterstern, and A. P. Levy
Haptoglobin Genotype Is a Major Determinant of the Amount of Iron in the Human Atherosclerotic Plaque
J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1049 - 1051.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Costacou, R. E. Ferrell, and T. J. Orchard
Haptoglobin Genotype: A Determinant of Cardiovascular Complication Risk in Type 1 Diabetes
Diabetes, June 1, 2008; 57(6): 1702 - 1706.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Papp, I. Foldi, E. Nemes, M. Udvardy, J. Harsfalvi, I. Altorjay, I. Mate, T. Dinya, C. Varvolgyi, Z. Barta, et al.
Haptoglobin Polymorphism: A Novel Genetic Risk Factor for Celiac Disease Development and Its Clinical Manifestations
Clin. Chem., April 1, 2008; 54(4): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The year in atherothrombosis.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Milman, S. Blum, C. Shapira, D. Aronson, R. Miller-Lotan, Y. Anbinder, J. Alshiek, L. Bennett, M. Kostenko, M. Landau, et al.
Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 341 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Leclercq, X. Houard, M. Philippe, V. Ollivier, U. Sebbag, O. Meilhac, and J.-B. Michel
Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment
J. Leukoc. Biol., December 1, 2007; 82(6): 1420 - 1429.
[Abstract] [Full Text] [PDF]